Results 151 to 160 of about 27,286 (175)
Some of the next articles are maybe not open access.
Physical Chemistry Chemical Physics, 2022
The interfacial behaviors of conjugated AS1411 molecules at lipid bilayer interfaces were investigated by SFG-VS. The AS1411 molecules at the DMTAP bilayer show a higher binding affinity but a slower binding kinetics compared to the DMDAP bilayer.
Li, Penghua +10 more
openaire +2 more sources
The interfacial behaviors of conjugated AS1411 molecules at lipid bilayer interfaces were investigated by SFG-VS. The AS1411 molecules at the DMTAP bilayer show a higher binding affinity but a slower binding kinetics compared to the DMDAP bilayer.
Li, Penghua +10 more
openaire +2 more sources
STUDY OF CATIONIC PORPHYRIN COMPLEXES WITH APTAMER AS1411 BY EPR AND OPTICAL SPECTROSCOPY
X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023: Cб. тез., 2023Porphyrins are photosensitizers (PS) for photodynamic therapy (PDT). However, the most effective PS have poor water solubility, which limits their application in PDT. The solution to this problem is the use of targeted drug delivery, such as the oligonucleotide AS1411.
T.A. Khlynova +2 more
openaire +1 more source
Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer
Drug Development and Industrial Pharmacy, 2018Melittin, a small water-soluble cationic amphipathic α-helical linear peptide, consisted of 26 amino acids, is the honeybee venom major constituent. Several reports have proved the lytic and apoptotic effects of melittin in several cancerous cell lines.
Seyed Hossein, Rajabnejad +5 more
openaire +2 more sources
Journal of Nanoscience and Nanotechnology, 2020
AS1411 Aptamer-functionalized liposome was successfully formulated and found to be nanosized. Flow cytometer and CLSM results demonstrated that Aptamer enhanced the targeting of carrier in the cancer cells via nucleolin-mediated transmembrane endocytosis pathway.
Lanyu, Jiang, Hui, Wang, Shaozheng, Chen
openaire +2 more sources
AS1411 Aptamer-functionalized liposome was successfully formulated and found to be nanosized. Flow cytometer and CLSM results demonstrated that Aptamer enhanced the targeting of carrier in the cancer cells via nucleolin-mediated transmembrane endocytosis pathway.
Lanyu, Jiang, Hui, Wang, Shaozheng, Chen
openaire +2 more sources
AS1411 aptamer in melanoma therapy: Harnessing targeted strategies for precision treatment
Pathology - Research and PracticeMelanoma, the fifth most prevalent cancer type in both men and women, is characterized by substantial incidence and mortality rates. Melanoma treatment varies by stage and may include surgery, chemotherapy, immunotherapy, and targeted therapies. The AS1411 aptamer, which targets the overexpressed nucleolin protein in melanoma cells, has emerged as a ...
Monireh Askarzadeh +4 more
openaire +2 more sources
In silico activity of AS1411 aptamer against nucleolin of cancer cells
2021The support of this work by the research council of Isfahan University of Medical Sciences under grant number 298096 and ethics code IR.MUI.RESEARCH.
Farahbakhsh, Z. +4 more
openaire +1 more source
Biomaterials, 2014
BRAF gene mutation is found in more than 60% of malignant melanomas, which are difficult to treat. In this study, a new tumor-targeting liposome was developed to deliver anti-BRAF siRNA (siBraf) for the treatment of melanomas. Nucleolin is overexpressed on the surface of cancer cells.
Liyu, Li +6 more
openaire +2 more sources
BRAF gene mutation is found in more than 60% of malignant melanomas, which are difficult to treat. In this study, a new tumor-targeting liposome was developed to deliver anti-BRAF siRNA (siBraf) for the treatment of melanomas. Nucleolin is overexpressed on the surface of cancer cells.
Liyu, Li +6 more
openaire +2 more sources
Characterizing Oligonucleotide Uptake in Cultured Cells: A Case Study Using AS1411 Aptamer
2019Oligonucleotides can be designed or evolved to bind to specific DNA, RNA, protein, or small molecule targets and thereby alter the biological function of the target. The therapeutic potential of oligonucleotides targeted to intracellular molecules will depend largely on their ability to be taken up by the cells of interest, as well as their subsequent ...
Elsa M, Reyes-Reyes, Paula J, Bates
openaire +2 more sources
Tumor targeting with a99mTc-labeled AS1411 aptamer in prostate tumor cells
Journal of Drug Targeting, 2015AS1411, a 26-base guanine-rich oligonucleotide aptamer, has high affinity to nucleolin, mainly on tumor cell surfaces. In this study, a modified AS1411 was labeled with (99m)Tc and evaluated as a potential tumor-targeting agent for imaging. The AS1411 aptamer was conjugated with HYNIC and labeled with (99m)Tc in the presence a co-ligand.
Zohreh, Noaparast +3 more
openaire +2 more sources
AS1411, a Novel DNA Aptamer as a Potential Treatment of Acute Myelogenous Leukaemia (AML).
Blood, 2006Abstract AS1411 (formerly AGRO100) is the first nucleic acid aptamer to enter oncology trials and is currently in a Phase I study in renal and lung patients. AS1411 is a 26mer unmodified phosphodiester-based guanosine rich oligonucleotide which, as a dimer, forms a serum-resistant quartet structure.
Kirti Shah +4 more
openaire +1 more source

